scholarly journals Urocortin II Regulates NFAT Transcription Factor in Adult Rabbit Cardiac Myocytes

2012 ◽  
Vol 102 (3) ◽  
pp. 525a
Author(s):  
Stefanie Walther ◽  
Lothar A. Blatter
Immunity ◽  
2008 ◽  
Vol 29 (5) ◽  
pp. 704-719 ◽  
Author(s):  
Stéphane Bécart ◽  
Ann J. Canonigo Balancio ◽  
Céline Charvet ◽  
Sonia Feau ◽  
Caitlin E. Sedwick ◽  
...  

1997 ◽  
Vol 273 (3) ◽  
pp. H1403-H1407 ◽  
Author(s):  
S. Yasuda ◽  
W. Y. Lew

Lipopolysaccharide (LPS) induces cardiac depression by activating nitric oxide pathways to increase guanosine 3',5'-cyclic monophosphate (cGMP), a second messenger of nitric oxide. Endothelin-1 (ET-1) may interact with nitric oxide pathways. We hypothesized that ET-1 modulates LPS-induced contractile depression in cardiac myocytes. Adult rabbit cardiac myocytes exposed to LPS (10 ng/ml) developed decreased cell shortening after 6 h, with an increase in cardiac cGMP levels [606 +/- 36 (SE) fmol/mg protein] compared with control myocytes (360 +/- 26 fmol/mg protein, P < 0.05). LPS effects were completely blocked by coincubation with the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (1 mM). Coincubation with ET-1 (10 nM) attenuated the contractile depression and increase in cGMP with LPS (482 +/- 28 fmol/mg protein, P < 0.05 vs. LPS alone). ET-1 alone did not alter cGMP levels (350 +/- 30 fmol/mg protein). ET-1 effects on contractile function were blocked by BQ-123 (10 microM), a selective ET-1 type A receptor antagonist. We conclude that ET-1 ameliorates LPS-induced contractile depression in cardiac myocytes by attenuating LPS effects on nitric oxide-cGMP pathways.


2010 ◽  
Vol 138 (5) ◽  
pp. S-683
Author(s):  
Gerrit John ◽  
Zhenwu Lin ◽  
John P. Hegarty ◽  
Arthur Berg ◽  
Danielle M. Pastor ◽  
...  

2004 ◽  
Vol 27 (7) ◽  
pp. 738-741 ◽  
Author(s):  
Xing Fu Cai ◽  
Im Seon Lee ◽  
Nguyen Tien Dat ◽  
Guanghai Shen ◽  
Jong Seong Kang ◽  
...  

1999 ◽  
Vol 19 (3) ◽  
pp. 2300-2307 ◽  
Author(s):  
Chi-Wing Chow ◽  
Mercedes Rincón ◽  
Roger J. Davis

ABSTRACT The nuclear factor of activated T cells (NFAT) transcription factor is implicated in expression of the cytokine interleukin-2 (IL-2). Binding sites for NFAT are located in the IL-2 promoter. Furthermore, pharmacological studies demonstrate that the drug cyclosporin A inhibits both NFAT activation and IL-2 expression. However, targeted disruption of the NFAT1 and NFAT2 genes in mice does not cause decreased IL-2 secretion. The role of NFAT in IL-2 gene expression is therefore unclear. Here we report the construction of a dominant-negative NFAT mutant (dnNFAT) that selectively inhibits NFAT-mediated gene expression. The inhibitory effect of dnNFAT is mediated by suppression of activation-induced nuclear translocation of NFAT. Expression of dnNFAT in cultured T cells caused inhibition of IL-2 promoter activity and decreased expression of IL-2 protein. Similarly, expression of dnNFAT in transgenic mice also caused decreased IL-2 gene expression. These data demonstrate that NFAT is a critical component of the signaling pathway that regulates IL-2 expression.


ChemInform ◽  
2006 ◽  
Vol 37 (8) ◽  
Author(s):  
Tien Dat Nguyen ◽  
Xing Fu Cai ◽  
Quanghai Shen ◽  
Im Seon Lee ◽  
Eun Joo Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document